cyclosporine and Hodgkin Disease

cyclosporine has been researched along with Hodgkin Disease in 17 studies

Research

Studies (17)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's7 (41.18)18.2507
2000's9 (52.94)29.6817
2010's0 (0.00)24.3611
2020's1 (5.88)2.80

Authors

AuthorsStudies
Chan, WC; Chen, L; Chen, R; Forman, SJ; Guo, Y; Herrera, AF; Hou, J; Kwak, LW; Mei, M; Newman, EM; Ngo, VN; Popplewell, L; Puverel, S; Rosen, ST; Song, JY; Synold, TW; Tao, S; Wu, J; Wu, X; Yi, S1
Hoyle, C; Kazmi, M; Radia, D; Schey, SA; Streetly, M1
Alvarez, I; Arranz, R; Caballero, D; Canales, M; Cavet, J; Garcia-Conde, J; Goldstone, AH; Hunter, A; Linch, DC; Mackinnon, S; Mahendra, P; Milligan, D; Parker, A; Peggs, KS; Qian, W; Ribera, JM; Sanz, G; Sierra, J; Sureda, A; Thomson, K; Urbano-Ispizua, A1
Ambinder, RF; Anders, V; Bolaños-Meade, J; Borrello, IM; Brodsky, R; Flinn, IW; Fuchs, EJ; Garrett-Mayer, E; Hess, AD; Huff, CA; Jones, RJ; Kasamon, YL; Luznik, L; Matsui, W; Swinnen, LJ; Vogelsang, GB; Webb, J1
Aggarwal, N; Batwara, R; McCarthy, ET; Savin, VJ; Sharma, M; Sharma, R1
Hanke, C; Jüttner, E; Lauten, M; Niemeyer, CM; Pohl, M; Rohr, JC; Wacker, HH; Wagner, HJ1
Bartoli, E; Boiocchi, M; Carbone, A; Casatta, L; De Vita, S; Dolcetti, R; Ferraccioli, GF1
Allard, C; Benoit, S; Deschênes, G; Lamagnére, JP; Lejars, O; Nivet, H1
Burrell, LM; Mangan, KF; Mullaney, M; Redmond, J; Reid, TJ1
Kwen, PL; Pullicino, P; Zimmer, W1
Shechter, P1
Hood, IM; Mahendra, P; Marcus, RE; McNeil, K1
Hołowiecki, J; Kopera, M; Krawczyk-Kuliś, M; Kruzel, T; Markiewicz, M; Wojciechowska, M; Wojnar, J1
Allerberger, F; Gruber, J; Krugmann, J; Müller, T; Offner, FA; Sailer-Höck, M1
Carella, AM; Cavaliere, M; Corsetti, MT; De Stefano, F; Ferrara, R; Lambelet, P; Lerma, E; Loni, C; Pinotti, G; Romanelli, A; Tedeschi, L; Valbonesi, M; Verdiani, S; Vinci, M1
Baron, F; Beguin, Y; Fillet, G; Gothot, A; Hermanne, JP; Pierard, GE; Salmon, JP1
Barrett, AJ; Carter, C; Childs, R; de Witte, M; Kang, EM; Leitman, SF; Little, R; Malech, H; Morgan, RA; Phang, S; Tisdale, JF1

Trials

5 trial(s) available for cyclosporine and Hodgkin Disease

ArticleYear
Inhibition of MDR1 Overcomes Resistance to Brentuximab Vedotin in Hodgkin Lymphoma.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2020, 03-01, Volume: 26, Issue:5

    Topics: Adult; Aged; Animals; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B; Brentuximab Vedotin; Cell Line, Tumor; Cell Proliferation; Cyclosporine; Drug Resistance, Neoplasm; Female; Hodgkin Disease; Humans; Male; Mice; Mice, Inbred NOD; Mice, SCID; Middle Aged; Prospective Studies; Reed-Sternberg Cells; Treatment Outcome; Xenograft Model Antitumor Assays; Young Adult

2020
Second autologous transplant with cyclosporin/interferon alpha-induced graft versus host disease for patients who have failed first-line consolidation.
    Bone marrow transplantation, 2004, Volume: 33, Issue:11

    Topics: Adult; Cyclosporine; Female; Graft vs Host Disease; Graft vs Host Reaction; Hodgkin Disease; Humans; Immunologic Factors; Interferon-alpha; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Pilot Projects; Salvage Therapy; Survival Analysis; Transplantation, Autologous; Treatment Outcome

2004
Reduced-intensity conditioning for allogeneic haematopoietic stem cell transplantation in relapsed and refractory Hodgkin lymphoma: impact of alemtuzumab and donor lymphocyte infusions on long-term outcomes.
    British journal of haematology, 2007, Volume: 139, Issue:1

    Topics: Adult; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antineoplastic Agents; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lymphocyte Depletion; Lymphocyte Transfusion; Male; Melphalan; Methotrexate; Middle Aged; Multivariate Analysis; Myeloablative Agonists; Proportional Hazards Models; Retrospective Studies; Survival Analysis; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Vidarabine

2007
Induction of autologous graft-versus-host disease: results of a randomized prospective clinical trial in patients with poor risk lymphoma.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2007, Volume: 13, Issue:10

    Topics: Adult; Cyclosporine; Female; Graft vs Tumor Effect; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Immunosuppressive Agents; Interferon-gamma; Interleukin-2; Lymphoma, Non-Hodgkin; Male; Neoplasm Recurrence, Local; Recombinant Proteins; Salvage Therapy; Survival Analysis; Syndrome; Transplantation Conditioning; Transplantation, Autologous

2007
Autografting followed by nonmyeloablative immunosuppressive chemotherapy and allogeneic peripheral-blood hematopoietic stem-cell transplantation as treatment of resistant Hodgkin's disease and non-Hodgkin's lymphoma.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Dec-01, Volume: 18, Issue:23

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Cyclosporine; Cytarabine; Etoposide; Female; Graft vs Tumor Effect; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Immunosuppressive Agents; Lymphoma, Non-Hodgkin; Male; Melphalan; Methotrexate; Middle Aged; Pilot Projects; Risk Factors; Survival Rate; Transplantation Chimera; Vidarabine

2000

Other Studies

12 other study(ies) available for cyclosporine and Hodgkin Disease

ArticleYear
Serum permeability activity in steroid-resistant minimal change nephrotic syndrome is abolished by treatment of Hodgkin disease.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2007, Volume: 50, Issue:5

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Comorbidity; Cyclosporine; Glomerular Filtration Rate; Hodgkin Disease; Humans; Immunosuppressive Agents; Kidney Glomerulus; Male; Nephrosis, Lipoid; Permeability; Remission Induction

2007
Differentiation of EBV-induced post-transplant Hodgkin lymphoma from Hodgkin-like post-transplant lymphoproliferative disease.
    Pediatric transplantation, 2008, Volume: 12, Issue:4

    Topics: Adolescent; Antineoplastic Agents; Child; Cyclosporine; Diagnosis, Differential; Epstein-Barr Virus Infections; Herpesvirus 4, Human; Hodgkin Disease; Humans; Immunosuppressive Agents; Kidney Transplantation; Liver Transplantation; Lymph Nodes; Lymphoproliferative Disorders; Male

2008
Epstein-Barr virus-associated Hodgkin's lymphoma in a rheumatoid arthritis patient treated with methotrexate and cyclosporin A.
    Arthritis and rheumatism, 1995, Volume: 38, Issue:6

    Topics: Arthritis, Rheumatoid; Cyclosporine; Drug Therapy, Combination; Herpesviridae Infections; Herpesvirus 4, Human; Hodgkin Disease; Humans; Male; Methotrexate; Middle Aged; Tumor Virus Infections

1995
Hodgkin's disease following steroid-resistant idiopathic nephrotic syndrome.
    Pediatric nephrology (Berlin, Germany), 1994, Volume: 8, Issue:3

    Topics: Child; Cyclosporine; Drug Resistance; Hodgkin Disease; Humans; Lymph Nodes; Male; Mediastinum; Nephrotic Syndrome; Prednisone

1994
Pure red cell aplasia after chemotherapy for Hodgkin's lymphoma: in vitro evidence for T cell mediated suppression of erythropoiesis and response to sequential cyclosporin and erythropoietin.
    American journal of hematology, 1994, Volume: 46, Issue:1

    Topics: Adult; Colony-Forming Units Assay; Cyclosporine; Erythroid Precursor Cells; Erythropoiesis; Erythropoietin; Female; Hodgkin Disease; Humans; Red-Cell Aplasia, Pure; T-Lymphocytes

1994
Posterior leucoencephalopathy syndrome.
    Lancet (London, England), 1996, Jun-01, Volume: 347, Issue:9014

    Topics: Adult; Bone Transplantation; Brain; Brain Edema; Cyclosporine; Hodgkin Disease; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Syndrome; Tacrolimus

1996
Acute tubular necrosis following high-dose cyclosporine A therapy.
    European journal of clinical pharmacology, 1996, Volume: 49, Issue:6

    Topics: Adult; Cyclosporine; Drug Resistance, Multiple; Fluorescence Polarization; Hodgkin Disease; Humans; Immunosuppressive Agents; Infusions, Intravenous; Kidney Tubular Necrosis, Acute; Male

1996
Hodgkin's disease after cardiac transplant: a report of two cases.
    Clinical and laboratory haematology, 1996, Volume: 18, Issue:2

    Topics: Adult; Antibodies, Viral; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Chlorambucil; Cyclosporine; Fatal Outcome; Heart Transplantation; Heart-Lung Transplantation; Herpesviridae Infections; Herpesvirus 4, Human; Histiocytosis, Langerhans-Cell; Hodgkin Disease; Humans; Immunosuppressive Agents; Lung Diseases, Fungal; Male; Middle Aged; Myocarditis; Postoperative Complications; Prednisolone; Prednisone; Procarbazine; Tumor Virus Infections; Vinblastine

1996
Allogeneic and autologous bone marrow transplantation in single centre experience.
    Bone marrow transplantation, 1998, Volume: 22 Suppl 4

    Topics: Adult; Bone Marrow Transplantation; Cyclosporine; Graft vs Host Disease; Hodgkin Disease; Humans; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Registries; Transplantation, Autologous; Transplantation, Homologous

1998
Epstein-Barr virus-associated Hodgkin's lymphoma and legionella pneumophila infection complicating treatment of juvenile rheumatoid arthritis with methotrexate and cyclosporine A.
    Human pathology, 2000, Volume: 31, Issue:2

    Topics: Arthritis, Rheumatoid; Cyclosporine; Epstein-Barr Virus Infections; Fatal Outcome; Female; Hodgkin Disease; Humans; Immunosuppressive Agents; Infant; Legionnaires' Disease; Methotrexate

2000
Clinical course and predictive factors for cyclosporin-induced autologous graft-versus-host disease after autologous haematopoietic stem cell transplantation.
    British journal of haematology, 2000, Volume: 111, Issue:3

    Topics: Acute Disease; Adolescent; Adult; Age Factors; Aged; Breast Neoplasms; Chi-Square Distribution; Child; Child, Preschool; Cyclosporine; Disease-Free Survival; Female; Graft vs Leukemia Effect; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; HLA-B Antigens; HLA-DR6 Antigen; Hodgkin Disease; Humans; Immunosuppressive Agents; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multiple Myeloma; Myelodysplastic Syndromes; Prospective Studies; Transplantation, Autologous

2000
Nonmyeloablative conditioning followed by transplantation of genetically modified HLA-matched peripheral blood progenitor cells for hematologic malignancies in patients with acquired immunodeficiency syndrome.
    Blood, 2002, Jan-15, Volume: 99, Issue:2

    Topics: Acquired Immunodeficiency Syndrome; Acute Disease; Adult; Anti-Bacterial Agents; Antiretroviral Therapy, Highly Active; Cyclophosphamide; Cyclosporine; Feasibility Studies; Ganciclovir; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Infection Control; Leukemia, Myeloid; Prednisone; Premedication; Recurrence; Remission Induction; Transplantation Conditioning; Treatment Outcome; Vidarabine; Viral Load

2002